Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
Jun. 03 | Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft... | |
Jun. 03 | Transcript : DSM-Firmenich AG - Analyst/Investor Day |
Sales 2024 * | 12.6B 13.61B | Sales 2025 * | 13.29B 14.35B | Capitalization | 26.47B 28.59B |
---|---|---|---|---|---|
Net income 2024 * | 444M 480M | Net income 2025 * | 791M 854M | EV / Sales 2024 * | 2.33 x |
Net Debt 2024 * | 2.92B 3.15B | Net Debt 2025 * | 2.66B 2.87B | EV / Sales 2025 * | 2.19 x |
P/E ratio 2024 * |
58.6
x | P/E ratio 2025 * |
33.6
x | Employees | 28,685 |
Yield 2024 * |
2.51% | Yield 2025 * |
2.47% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 342 M€ | +17.65% | ||
1.13% | 21 M€ | +8.41% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.68% | 893B | |
+3.75% | 248B | |
+26.87% | 177B | |
-0.44% | 136B | |
+60.77% | 96.68B | |
-8.22% | 71.74B | |
-7.74% | 55.81B | |
+32.82% | 35.41B | |
-40.96% | 30.22B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock